Antara Capital LP

In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 14, 2025), Antara Capital LP reported 2 stock positions worth $484 thousand. Its top holding was Currenc (CURR) at 91.4% of the portfolio, followed by Aspire Biopharma (8.6%). Compared with Q2 2025, it opened 1 new position, sold out of 1 and reduced 1. The biggest buy was a new position in Aspire Biopharma and the biggest sale an exit from Rezolve AI (RZLV).

Most Recent 13F
Q4 2025
Location
New York, NY
CIK
0001750183
Portfolio Value
$484K (Q3 2025)
SEC Filing
0001750183-25-000016 ↗ filed Nov 14, 2025

Holdings Value

0$20.0M$40.0M$60.0M Q1 2024: $40.5M Q1 2024 Q2 2024: $59.6M Q2 2024 Q3 2024: $18.1M Q3 2024 Q4 2024: $23.1M Q4 2024 Q1 2025: $27K Q1 2025 Q2 2025: $1.1M Q2 2025 Q3 2025: $484K $484K Q3 2025 Q4 2025: $27K Q4 2025

Holdings 2 stocks · $484K
CURR Currenc Group Inc. 91.36% 263,200 $442K Reduce -70.0%
ASPIRE BIOPHARMA HLDGS INC 8.64% 202,897 $42K New
Other holdings (1): bonds, preferreds, convertibles and warrants · $6K (not counted above)
SecurityClassShares / PrincipalValueChange
ASBPW Aspire Biopharma Holdin-CW27 *W EXP 02/14/203 207,693$6KNew

Total filed on the 13F, all lines: $490K.

Portfolio Sells Q2 2025 → Q3 2025
RZLV Rezolve AI PLC Sold out 0.00% −36.05
CURR Currenc Group Inc. Reduce -70.0% 91.36% +27.41

Portfolio Buys Q2 2025 → Q3 2025
ASPIRE BIOPHARMA HLDGS INC New 8.64% +8.64

Notes & Other Activity Q2 2025 → Q3 2025
ASBPW Aspire Biopharma Holdin-CW27 *W EXP 02/14/203 New 207,693 $6K

Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q4 2025 1$27KASPIRE BIOPHARMA HLDGS INC
Q3 2025 2$484KCURR, ASPIRE BIOPHARMA HLDGS INC
Q2 2025 2$1.1MCURR, RZLV
Q1 2025 2$27KTHCH, LONGEVITY HEALTH HLDGS INC
Q4 2024 7$23.1MBRSL, BUR, NKLAQ, INVZ, MANU
Q3 2024 9$18.1MEDR, INVZ, CZR, BRSL, BUR
Q2 2024 10$59.6MCHPT, ACI, BRSL, BUR, KR
Q1 2024 9$40.5MSHY, CHPT, UHG, ACI, ALTERNUS CLEAN ENERGY INC